By identifying promising discoveries and advancing their translation, CCRM has enabled and supported new companies. As of November 2024, we have founded one company, incubated one company, co-founded three companies, and supported the launch of 13 more (18 total) that together have raised more than CA $1.2B. (Not all company logos are included here.)

Portfolio Companies

IC-fullmember_0000s_0024_aspect
Endogena Therapeutics
External link to ExCellThera
Feldan Therapeutics
Intelligent Vector Solutions - iVexSol logo
Kisoji Biotechnology
LineaBio logo
Mesentech
Morophocell Technologies
Notch Therapeutics

Past Exits

Learn more on our Investing Strategy and Funding and Strategic Support pages.